Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Merit Medical Systems, Inc.    MMSI

MERIT MEDICAL SYSTEMS, INC.

(MMSI)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Merit Medical Systems to Announce Fourth Quarter and Year End Results and 2019 Guidance on February 26, 2019

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 09:26am EDT

SOUTH JORDAN, Utah, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2018 and guidance for the year ending December 31, 2019, after the close of the stock market on Tuesday, February 26, 2019.

Merit will hold its investor conference call (conference ID 9186535) on the same day (Tuesday, February 26, 2019) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).  The telephone numbers to call are (domestic) (844) 578-9672; and (international) (508) 637-5656.  A live webcast will also be available for the conference call at merit.com.

ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 5,800 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose and Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.

Contact: Anne-Marie Wright, Vice President, Corporate Communications
Phone: (801) 208-4167  e-mail: awright@merit.com  Fax: (801) 253-1688

 

Merit Medical Systems, Inc. Logo


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERIT MEDICAL SYSTEMS, INC
04/11MERIT MEDICAL : Additional proxy soliciting materials - definitive
PU
04/10Merit Medical Systems to Announce First Quarter Results on April 23, 2019
GL
03/29MERIT MEDICAL : to Present at Needham Healthcare Conference
AQ
03/28Merit Medical to Present at Needham Healthcare Conference
GL
03/22MERIT MEDICAL : Embosphere® Microspheres Now Cleared For Embolization Of Blood V..
PU
03/12MERIT MEDICAL SYSTEMS INC : Change in Directors or Principal Officers (form 8-K)
AQ
03/01MERIT MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
AQ
02/26MERIT MEDICAL SYSTEMS INC : Results of Operations and Financial Condition, Regul..
AQ
02/26MERIT MEDICAL : Reports Earnings for Fourth Quarter and Year Ended December 31, ..
AQ
02/22Merit Medical to Participate at Six Upcoming Conferences
GL
More news
Financials ($)
Sales 2019 1 021 M
EBIT 2019 151 M
Net income 2019 73,6 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 46,78
P/E ratio 2020 33,28
Capi. / Sales 2019 3,11x
Capi. / Sales 2020 2,85x
Capitalization 3 170 M
Chart MERIT MEDICAL SYSTEMS, INC.
Duration : Period :
Merit Medical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERIT MEDICAL SYSTEMS, INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 70,7 $
Spread / Average Target 23%
EPS Revisions
Managers
NameTitle
Fred P. Lampropoulos Chairman, President & Chief Executive Officer
Ronald A. Frost Chief Operating Officer
Raul Parra Chief Financial Officer
Joseph Pierce Chief Information Officer
Jason Treft Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
MERIT MEDICAL SYSTEMS, INC.3.31%3 170
HENRY SCHEIN-1.78%9 192
AMPLIFON19.36%4 294
CANTEL MEDICAL CORP.-13.26%2 694
PATTERSON COMPANIES8.55%2 031
SHIP HEALTHCARE HOLDINGS INC13.12%1 978